Procter & Gamble CoPG:NYQ

80.99
1.09 / 1.36%
9.31m
5.86 %
0.467
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Feb 12 2016 21:02 GMT.

Consensus recommendation

As of Feb 12, 2016, the consensus forecast amongst 23 polled investment analysts covering Procter & Gamble Co advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jan 18, 2016. The previous consensus forecast advised investors to hold their position in Procter & Gamble Co.

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
Buy6
Outperform3
Hold12
Underperform2
Sell0
No opinion0

Share price forecast

The 19 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 84.00, with a high estimate of 94.00 and a low estimate of 75.00. The median estimate represents a 3.72% increase from the last price of 80.99. View Full Financials

High+16.1 %94.00
Med+3.7 %84.00
Low-7.4 %75.00

Dividends

In 2015, Procter & Gamble Co reported a dividend of 2.59 USD, which represents a 5.71% increase over last year. The 12 analysts covering the company expect dividends of 2.68 USD for the upcoming fiscal year, an increase of 3.55%. View Full Financials

Div growth (TTM)+5.71 %
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Jan 26, 2016, Procter & Gamble Co reported 2nd quarter 2016 earnings of 1.04 per share. This result exceeded the 0.98 consensus of the 22 analysts covering the company and under-performed last year's 2nd quarter results by 1.89 %.
The next earnings announcement is expected on Apr 26, 2016. View Full Interim Financials

Average growth rate-0.10 %

Procter & Gamble Co reported annual 2015 earnings of 4.02 per share on Jul 30, 2015. View Full Annual Financials

Average growth rate+0.53 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement

Revenue

The Procter & Gamble Company had 2nd quarter 2016 revenues of 16.92bn. This missed the 16.94bn consensus estimate of the 19 analysts following the company. This was 16.10 % below the prior year's 2nd quarter results. View Full Interim Financials

Average growth rate-4.18 %

The Procter & Gamble Company had revenues for the full year 2015 of 76.28bn. This was 8.17 % below the prior year's results. View Full Annual Financials

Average growth rate-1.88 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.